Stock GHDN BRAINSTORM CELL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG

Equities

GHDN

US10501E2019

Delayed Deutsche Boerse AG
Other stock markets
 11:53:56 23/05/2024 am IST 		5-day change 1st Jan Change
0.519 EUR -7.49% Intraday chart for Brainstorm Cell Therapeutics Inc. +19.17% +125.65%
20/05 BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit from Longer-Term Treatment with NurOwn CI
17/04 Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024
CI
Brainstorm Cell Therapeutics Inc. Announces Management Changes
CI
Brainstorm Cell Therapeutics Inc. Announces Executive Changes
CI
Brainstorm Cell Therapeutics Inc. Announces Resignation of Dr. Kirk Taylor as EVP and Chief Medical Officer
CI
BrainStorm Cell Therapeutics Inc. Appoints Bob Dagher as Executive Vice President and Chief Development Officer
CI
Brainstorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair
CI
Brainstorm Cell Therapeutics Chief Operating Officer David Setboun Resigns
MT
Brainstorm Cell Therapeutics Inc Announces Resignation of David Setboun as Executive Vice President and Chief Operating Officer
CI
Brainstorm Cell Therapeutics Inc. Announces Appointment of Kirk Taylor as Executive Vice President and Chief Medical Officer, Effective May 1, 2023
CI
BrainStorm Cell Therapeutics Announces Promotion of Dr. Stacy Lindborg to Co-Chief Executive Officer
CI
Brainstorm Cell Therapeutics Inc. Appoints Antal Pearl-Lendner as Chief Legal Counsel
CI
Brainstorm Cell Therapeutics Inc. Announces Retirement of Sankesh Abbhi as Board of Director
CI
Brainstorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
CI
Brainstorm Cell Therapeutics Inc. Announces Board Changes
CI
Cidara Therapeutics : Appoints Preetam Shah Chief Financial Officer
MT
Brainstorm Cell Therapeutics Inc. Announces Executive Changes
CI
Brainstorm Cell Therapeutics Inc. Appoints William K. White as Senior Vice President, Head of Market Access & Pricing
CI
Brainstorm Cell Therapeutics Inc. Appoints Anthony Waclawski as Executive Vice President, Global Head of Regulatory Affairs
CI
Brainstorm Appoints Stacy R. Lindborg, as Executive Vice President, Head of Global Clinical Research
CI
BrainStorm Cell Therapeutics, Inc. Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. GHDN Stock
  5. News Brainstorm Cell Therapeutics Inc.
  6. Insiders